Skip to content
Review

Innovative Technologies in Social

· 0 citations · 60 references

TL;DR

Overall, current evidence indicates that psilocybin is a promising intervention for TRD with a manageable safety profile in controlled settings, Nevertheless, large-scale, long-term randomized trials are required to determine the durability of its effects and to establish standardized treatment protocols.

View source

Similar papers

Review Open access Sep 2026

EFFICACY AND SAFETY OF PSILOCYBIN IN TREATMENT-RESISTANT DEPRESSION: A REVIEW

Major depressive disorder (MDD) is one of the leading causes of disability worldwide. A substantial proportion of patients fail to achieve remission through standard monoaminergic therapies, meeting the clinical criteria for treatment-resistant depression (TRD). TRD is associated with significant clinical morbidity and...

Mateusz Gawin, Emilia Koziara, Mateusz Gadzina et al. · 0 citations
Review Open access Aug 2026

Newer Therapeutic Approaches in Major Depressive Disorder

The current review tries to highlight the various options for treatment of depression for effective treatment of depression by opening up avenues for treatment of currently unanswered area for depression.

Jaspreet Kaur, Deepika Puri, K. Sachdeva et al. · 0 citations
Review

Innovative Technologies in Social

Przemysław Dominik, Drabik, Diana Morawska et al. · 0 citations
Review Open access Sep 2026

Treatment-Resistant Depression: A Literature Review of Innovative and Emerging Treatment Strategies

Introduction and objective: Major depressive disorder (MDD) is a heterogeneous psychiatric condition characterized by affective, cognitive and somatic symptoms that considerably impair daily functioning. It is defined clinically by prolonged low mood, diminished interest or pleasure, and a range of associated disturban...

Maciej Kisielewski, Natalia Fidut, Jakub Skrzypek et al. · 0 citations
Review Open access Sep 2026

Physical Therapy for Treatment-Resistant Depression A Comprehensive Review of Efficacy, Safety, and Evidence Grading

Abstract Major depressive disorder (MDD) is a common psychiatric illness that is primarily treated with antidepressant medications in clinical practice. Depression that responds poorly to antidepressant therapy is referred to as treatment-resistant depression (TRD). However, the definition and pathogenesis of TRD are u...

Wen-Xia Jiang, Hao-Ran Xing, Yun-Cheng Bai et al. · 0 citations
Review Open access Sep 2026

Multilevel Mechanisms and Clinical Efficacy of Psilocybin in Depression Treatment: A Systematic Review

It is suggested that psilocin, the active metabolite, may exert antidepressant effects through multilevel mechanisms, including brain-derived neurotrophic factor (BDNF)-tropomyosin receptor kinase B(TrkB) signaling, hippocampal neurogenesis, and default mode network functional connectivity remodeling.

Xi-Zhen Zhang, Xiao-Wen Zhang, Hai-Yu Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.